Grifols (GRFS) Asset Utilization Ratio (2011 - 2020)
Grifols' (GRFS) quarterly Asset Utilization Ratio came in at 0.61 in Q1 2020, up 17.05% YoY from 0.52 in Q2 2019, and down 4.68% on a QoQ basis from 0.64 in Q4 2019.
Grifols (GRFS) Asset Utilization Ratio (2011 - 2020) Analysis & Trends
Grifols (GRFS) has 10 years of Asset Utilization Ratio data on file, last reported at 0.61 in Q1 2020.
- Quarterly Asset Utilization Ratio rose 17.05% year-over-year to 0.61 in Q1 2020, while the trailing twelve-month figure through Mar 2020 was 0.61 (up 17.05% YoY) and the FY2025 annual result came in at 0.76, down 54.24% from the prior year.
- Asset Utilization Ratio declined to 0.61 in Q1 2020, from 0.64 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.66 in Q4 2017 to a low of 0.42 in Q3 2016.
- A 5-year average of 0.53 and a median of 0.52 in 2018 frame the typical range for Asset Utilization Ratio.
- Annual changes were most pronounced in 2016 — Asset Utilization Ratio slumped 99.6% — and 2017, when it soared 32.54%.
- Tracing GRFS's Asset Utilization Ratio over 5 years: stood at 0.5 in 2016, then soared by 32.54% to 0.66 in 2017, then decreased by 17.66% to 0.55 in 2018, then climbed by 17.36% to 0.64 in 2019, then declined by 4.68% to 0.61 in 2020.
- The last three Asset Utilization Ratio figures came in at 0.61 (Q1 2020), 0.64 (Q4 2019), and 0.52 (Q1 2019), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 0.49 |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 0.47 |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 0.52 |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 0.53 |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 0.40 |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 0.58 |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 0.31 |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | 0.64 |
| 10 | Grifols | 5.45 Bn | 4.45 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 0.61 |
| Dec 31, 2019 | 0.64 |
| Mar 31, 2019 | 0.52 |
| Dec 31, 2018 | 0.55 |
| Sep 30, 2018 | 0.56 |
| Jun 30, 2018 | 0.51 |
| Mar 31, 2018 | 0.51 |
| Dec 31, 2017 | 0.66 |
| Dec 31, 2016 | 0.50 |
| Sep 30, 2016 | 0.42 |
| Jun 30, 2016 | 0.42 |
| Mar 31, 2016 | 0.42 |
| Dec 31, 2015 | 0.42 |
| Mar 31, 2015 | 106.02 |
| Dec 31, 2014 | 105.22 |
| Sep 30, 2014 | 610.67 |
| Jun 30, 2014 | 638.30 |
| Mar 31, 2014 | 586.00 |
| Dec 31, 2013 | 672.40 |
| Sep 30, 2013 | 994.11 |